N
ALDR

Natixis’s Alder Biopharmaceuticals ALDR Stock Holding History

Natixis’s Portfolio ALDR Stock Details ALDR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-64,525
Closed -$1.22M – 1017
2019
Q3 		$1.22M Buy
+64,525
New +$738K 0.01% 562

Natixis's ALDR Position: Q4 2019 in Review

Natixis sold out of Alder Biopharmaceuticals (ALDR) in Q4 2019, closing a stake of 64,525 shares — an estimated $1.22M sold.

Natixis first reported a position in ALDR in Q3 2019 and held it in 1 quarter. The position peaked at $1.22M in Q3 2019. 0 funds tracked by Wall St. Rank hold ALDR as of Q4 2019.

  • Natixis reported no remaining Alder Biopharmaceuticals position as of Q4 2019 after selling out during the quarter.
  • Natixis sold 64,525 Alder Biopharmaceuticals shares in Q4 2019, an estimated $1.22M.
  • Natixis first reported a position in Alder Biopharmaceuticals in Q3 2019 and held it in 1 quarter.
  • Natixis's Alder Biopharmaceuticals position peaked at $1.22M in Q3 2019.
  • 0 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q4 2019.

Based on Natixis's 13F filing for Q4 2019, filed 14 Feb 2020.